Vivet Therapeutics
Gene therapy development
- B2B
About Vivet Therapeutics
A company dedicated to developing innovative gene therapy treatments for orphan diseases by optimizing gene delivery and long-term expression in the liver
Key facts
- Industry
- Biotechnology Research
- Company size
- 11–50 employees
- Headquarters
- Paris, Île-de-France, France
- Founded
- 2016
- Revenue
- $5.2M – $40.9MTamtam estimate
- Website
- vivet-therapeutics.com
Vivet Therapeutics at a glance
Vivet Therapeutics is a B2B company in the Biotechnology Research industry, headquartered in Paris, Île-de-France, France.
Vivet Therapeutics was founded in 2016.
Vivet Therapeutics has 11–50 employees.
Vivet Therapeutics's revenue is $5.2M – $40.9M (Tamtam estimate).
Frequently asked questions about Vivet Therapeutics
What is Vivet Therapeutics's revenue?
Tamtam estimates Vivet Therapeutics's annual revenue at $5.2M – $40.9M.
How many employees does Vivet Therapeutics have?
Vivet Therapeutics has 11–50 employees.
Where is Vivet Therapeutics headquartered?
Vivet Therapeutics is headquartered in Paris, Île-de-France, France.
Selling to companies like Vivet Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies